As a leading global pharmaceutical company headquartered in Basel, Switzerland, Novartis was seeking a solution to enable deeper and accelerated patient engagement. The Innovative Medicines division of Novartis had a strategic objective of reaching patients faster. Considerable thought was given to evaluating how patient services, which represented a key strategic pillar of this initiative, should evolve.